BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Sep 15, 2026; 18(9): 120566
Published online Sep 15, 2026. doi: 10.4251/wjgo.120566
Table 2 Comparative outcomes of treatment modalities for early esophageal cancer
Outcome
EMR
ESD
Esophagectomy
En bloc resection rateLow–moderate (piecemeal common for larger lesions)High (> 90%-95%)Not applicable
R0 resection rateModerate (lower for large lesions)High (approximately 85%-95%)High
Local recurrence rateHigher (up to 10%-20%)Low (< 1%-5%)Very low
5-year overall survivalApproximately 85%-98% (selected patients)Approximately 90%-99% (selected patients)Approximately 85%-95%
Procedure-related mortalityVery low (< 0.5%)Very low (< 0.5%)Higher (2%-9%)
Major adverse eventsBleeding, stricturePerforation, stricturePulmonary complications, anastomotic leak


Write to the Help Desk